FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2021696580> ?p ?o ?g. }

• W2021696580 endingPage "976" @default.
• W2021696580 startingPage "964" @default.
• W2021696580 abstract "Background: Primary objective: evaluate the efficacy (time to recurrence of depressive symptoms) of once daily extended release quetiapine fumarate (quetiapine XR) as maintenance monotherapy treatment to prevent relapse for major depressive disorder (MDD). Methods: Time-to-event (maximum 52 weeks), double-blind, multicenter, randomized withdrawal, placebo-controlled study of quetiapine XR (50–300 mg/day) comprising four treatment phases: enrollment (up to 28 days), open-label run-in (4–8 weeks), open-label stabilization (12–18 weeks), and randomization (up to 52 weeks). Seven hundred and seventy-six patients stabilized on quetiapine XR were eligible for randomization (Montgomery–Åsberg Depression Rating Scale [MADRS] score ≤12 and Clinical Global Impression-Severity of Illness [CGI-S] score ≤3); 391 received quetiapine XR and 385 received placebo (same dose as last open-label visit). Primary endpoint: time to recurrence of depressive event from randomization. Secondary outcomes included changes from randomization in MADRS total, CGI-S, Pittsburgh Sleep Quality Index (PSQI) global, and Hamilton Anxiety Rating Scale (HAM-A) total scores. Adverse events were recorded throughout. Results: Risk of recurrence of depressive event was significantly (P<.001) reduced by 66% (HR=.34; 95% CI: .25, .46) in patients randomized to continue with quetiapine XR versus patients randomized to switch to placebo. During the randomized phase, quetiapine XR maintained improvements in secondary outcomes (P<.001 for all): MADRS (0.15 versus 2.03), CGI-S (−0.03 versus 0.23); PSQI global (0.06 versus 1.35), and HAM-A total score (0.20 versus 1.58), respectively. The most common AEs (>10% any group) during the randomized period were headache and insomnia. Conclusions: Quetiapine XR maintenance therapy significantly reduced the risk of a depressive event in patients with MDD stabilized on quetiapine XR, with a safety and tolerability profile consistent with the known profile of quetiapine. Depression and Anxiety, 2010. © 2010 Wiley-Liss, Inc." @default.
• W2021696580 created "2016-06-24" @default.
• W2021696580 creator A5001747022 @default.
• W2021696580 creator A5032136657 @default.
• W2021696580 creator A5039822970 @default.
• W2021696580 creator A5071274095 @default.
• W2021696580 creator A5087356129 @default.
• W2021696580 creator A5090658899 @default.
• W2021696580 date "2010-08-23" @default.
• W2021696580 modified "2023-10-18" @default.
• W2021696580 title "Efficacy and tolerability of extended release quetiapine fumarate monotherapy as maintenance treatment of major depressive disorder: a randomized, placebo-controlled trial" @default.
• W2021696580 cites W1944222706 @default.
• W2021696580 cites W1971371348 @default.
• W2021696580 cites W1995358122 @default.
• W2021696580 cites W1996673522 @default.
• W2021696580 cites W1997010275 @default.
• W2021696580 cites W1999689270 @default.
• W2021696580 cites W2000778473 @default.
• W2021696580 cites W2002442062 @default.
• W2021696580 cites W2012655610 @default.
• W2021696580 cites W2022191212 @default.
• W2021696580 cites W2022424050 @default.
• W2021696580 cites W2025243014 @default.
• W2021696580 cites W2025326800 @default.
• W2021696580 cites W2041144155 @default.
• W2021696580 cites W2055052693 @default.
• W2021696580 cites W2057287568 @default.
• W2021696580 cites W2058147526 @default.
• W2021696580 cites W2060112644 @default.
• W2021696580 cites W2061314174 @default.
• W2021696580 cites W2073228294 @default.
• W2021696580 cites W2074852398 @default.
• W2021696580 cites W2078154303 @default.
• W2021696580 cites W2114613490 @default.
• W2021696580 cites W2131823335 @default.
• W2021696580 cites W2132577167 @default.
• W2021696580 cites W2151487996 @default.
• W2021696580 cites W2153381163 @default.
• W2021696580 cites W2160070901 @default.
• W2021696580 cites W2165044084 @default.
• W2021696580 cites W2165379748 @default.
• W2021696580 cites W2178264880 @default.
• W2021696580 doi "https://doi.org/10.1002/da.20740" @default.
• W2021696580 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20734365" @default.
• W2021696580 hasPublicationYear "2010" @default.
• W2021696580 type Work @default.
• W2021696580 sameAs 2021696580 @default.
• W2021696580 citedByCount "72" @default.
• W2021696580 countsByYear W20216965802012 @default.
• W2021696580 countsByYear W20216965802013 @default.
• W2021696580 countsByYear W20216965802014 @default.
• W2021696580 countsByYear W20216965802015 @default.
• W2021696580 countsByYear W20216965802016 @default.
• W2021696580 countsByYear W20216965802018 @default.
• W2021696580 countsByYear W20216965802019 @default.
• W2021696580 countsByYear W20216965802020 @default.
• W2021696580 countsByYear W20216965802021 @default.
• W2021696580 countsByYear W20216965802022 @default.
• W2021696580 countsByYear W20216965802023 @default.
• W2021696580 crossrefType "journal-article" @default.
• W2021696580 hasAuthorship W2021696580A5001747022 @default.
• W2021696580 hasAuthorship W2021696580A5032136657 @default.
• W2021696580 hasAuthorship W2021696580A5039822970 @default.
• W2021696580 hasAuthorship W2021696580A5071274095 @default.
• W2021696580 hasAuthorship W2021696580A5087356129 @default.
• W2021696580 hasAuthorship W2021696580A5090658899 @default.
• W2021696580 hasBestOaLocation W20216965801 @default.
• W2021696580 hasConcept C118552586 @default.
• W2021696580 hasConcept C126322002 @default.
• W2021696580 hasConcept C142724271 @default.
• W2021696580 hasConcept C15744967 @default.
• W2021696580 hasConcept C168563851 @default.
• W2021696580 hasConcept C197934379 @default.
• W2021696580 hasConcept C203092338 @default.
• W2021696580 hasConcept C204243189 @default.
• W2021696580 hasConcept C204787440 @default.
• W2021696580 hasConcept C27081682 @default.
• W2021696580 hasConcept C2776000289 @default.
• W2021696580 hasConcept C2776245837 @default.
• W2021696580 hasConcept C2776412080 @default.
• W2021696580 hasConcept C2776921671 @default.
• W2021696580 hasConcept C2777696351 @default.
• W2021696580 hasConcept C2778375690 @default.
• W2021696580 hasConcept C2779144063 @default.
• W2021696580 hasConcept C2780051608 @default.
• W2021696580 hasConcept C2780494398 @default.
• W2021696580 hasConcept C2780634440 @default.
• W2021696580 hasConcept C2781210498 @default.
• W2021696580 hasConcept C2911140283 @default.
• W2021696580 hasConcept C2983189541 @default.
• W2021696580 hasConcept C558461103 @default.
• W2021696580 hasConcept C71924100 @default.
• W2021696580 hasConceptScore W2021696580C118552586 @default.
• W2021696580 hasConceptScore W2021696580C126322002 @default.
• W2021696580 hasConceptScore W2021696580C142724271 @default.
• W2021696580 hasConceptScore W2021696580C15744967 @default.
• W2021696580 hasConceptScore W2021696580C168563851 @default.
• W2021696580 hasConceptScore W2021696580C197934379 @default.

• next